U.S. marijuana companies completed fewer capital raises in 2024 than in the year prior, but raised a good bit more money overall with the funding that did materialize, suggesting that some investors may be warming back up to the cannabis space.
That’s the macro takeaway from Viridian Capital Advisors’ latest update…
Please login to read all 322 words.
